<DOC>
	<DOCNO>NCT02186639</DOCNO>
	<brief_summary>To answer question whether disease specific profile breath patient COPD detect untargeted metabolomic study use exhale breath analysis mass spectrometry .</brief_summary>
	<brief_title>Breath Analysis Chronic Obstructive Lung Disease ( COPD )</brief_title>
	<detailed_description>This observational study compare volatile organic compound ( VOCs ) exhale breath COPD patient match control subject ( age , gender , smoking-state ) . 40 COPD patient ( 20 non-frequent , 20 frequent exacerbators ) 40 match control examine SESI-MS composition exhale breath identification COPD specific marker .</detailed_description>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>confirm COPD GOLD stage IIV , base postbronchodilator spirometry ( FEV1/FVC &lt; 0.7 ) perform within last 6 month age 18 80 year study entry healthy control : normal spirometry COPD exacerbation within last 6 week lung disease COPD acute inflammatory disease ( e.g . common cold ) within last 6 week acute chronic hepatic disease renal failure renal replacement therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>exhale breath</keyword>
	<keyword>volatile organic compound ( VOCs )</keyword>
	<keyword>SESI-MS</keyword>
</DOC>